debt_leverage_profile
1.01x Total Debt / Equity (Elevated leverage)
High
SEC-XBRL
interest_rate_sensitivity
Low direct sensitivity; minimal long-term debt, but equity financing dependency means higher rates increase dilution cost for cash-burn stage company
Inferred
Agent_Inference
geopolitical_supply_exposure
Low intensity; China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
Silicon nitride powder sourced primarily from Japan/Germany; ceramic processing equipment concentrated in Western Europe creates dual geopolitical chokepoints
Inferred
Agent_Inference
international_expansion_readiness
Minimal international revenue currently; negligible sovereign currency devaluation exposure as US-domestic revenue dominates defense and medical device contracts
Inferred
Agent_Inference
geographic_footprint
Predominantly US-based revenue; Salt Lake City operations hub with limited direct international market exposure, reducing currency devaluation risk materially
Inferred
Agent_Inference
commodity_exposure_profile
Low intensity; commodities: Active Pharmaceutical Ingredients, Rare Earth Elements, Natural Gas (energy), Plastics/Resins, Ethanol, Packaging Materials; geopolitical: China and India supply >60% of global API inputs, creating concentration risk.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
Yes; silicon nitride ceramic powder suppliers (Ube Industries, Japan) represent critical non-substitutable input with limited alternative qualified sources globally
Inferred
Agent_Inference
business_model_type_primary
Minimal cloud infrastructure dependency; primarily a materials manufacturing company; AWS/GCP/Azure termination would cause operational disruption but not existential failure
Inferred
Agent_Inference
business_model_type_secondary
Hardware/materials manufacturer with R&D services; cloud termination would disrupt data management and CAD workflows but physical production would continue
Inferred
Agent_Inference
switching_cost_profile
Low API coupling risk; not a software company; minimal third-party API dependencies in core ceramic manufacturing and product development operations
Inferred
Agent_Inference
howey_test_risk_index
Low Howey Test risk; revenue model based on tangible goods sales (ceramic components) and R&D contracts, not investment contracts or profit-sharing schemes
Inferred
Agent_Inference
regulatory_burden_tier
Very High
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
Low GDPR/CCPA exposure; limited consumer data collection; primary customers are institutional (DoD, medical OEMs) with B2B data governance frameworks
Inferred
Agent_Inference
antitrust_exposure_flag
Low antitrust risk; niche silicon nitride ceramics market with small market share; no dominant position triggering regulatory scrutiny
Inferred
Agent_Inference
regulatory_exposure_profile
Very High burden; regimes: FDA, CMS, HHS, HIPAA, EMA, OIG; Drug pricing legislation and approval delays directly compress revenue visibility.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
Predominantly transactional (~80%) via product sales and R&D contracts; limited recurring revenue; some multi-year defense contracts provide partial stability
Inferred
Agent_Inference
monetization_vector
Product sales of silicon nitride ceramic components plus R&D/development service contracts; defense and medical device OEM channels dominate revenue mix
Inferred
Agent_Inference
pricing_architecture
Cost-plus pricing on specialty ceramics with limited volume flexibility; under margin pressure if raw material or energy costs spike given small scale
Inferred
Agent_Inference
pricing_power_rating
Moderate; silicon nitride's unique biocompatibility and hardness properties provide some pricing power, but small scale limits negotiating leverage with large OEM buyers
Inferred
Agent_Inference
target_gross_margin_bracket
45.3% Gross Margin (Strong (40-60%))
High
SEC-XBRL
churn_vulnerability_index
No free-rider problem; physical product business with direct payment required; churn risk exists via OEM contract non-renewal or design-out from customer products
Inferred
Agent_Inference
headcount_cost_structure
Revenue growth is largely headcount-linear; ceramic manufacturing requires skilled labor and technicians scaling proportionally with production volume increases
Inferred
Agent_Inference
marginal_cost_of_growth
High marginal cost of growth; capacity expansion requires capital equipment investment and skilled headcount addition; limited software-like operating leverage
Inferred
Agent_Inference
franchise_compliance_risk
Not applicable; no franchise network
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, CAC likely improves modestly via reputation effects in defense/medical niches, but sales cycles remain long (12-24 months) limiting unit economics improvement
Inferred
Agent_Inference
network_effect_present
No meaningful network effects; physical materials business with no user-generated value loops; competitive moat relies on IP and manufacturing process expertise
Inferred
Agent_Inference
asset_efficiency_ratio
-109.0% Return on Assets (Negative equity)
High
SEC-XBRL
recession_resistance_tier
Moderate resilience; defense contracts provide some counter-cyclical buffer, but medical device OEM spending and spine implant markets are somewhat discretionary
Inferred
Agent_Inference
customer_segment_primary
Defense/military applications (DoD, prime contractors) for ballistic protection and armor; high concentration risk with government contract dependency
Inferred
Agent_Inference
customer_segment_secondary
Medical device OEMs for orthopedic/spine implant components; concentration risk if key OEM partners internalize manufacturing or switch biomaterial suppliers
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "19-0000 Life, Physical, and Social Science Occupations", "21-0000 Community and Social Service Occupations", "23-0000 Legal Occupations", "29-0000 Healthcare Practitioners and Technical Occupations", "31-0000 Healthcare Support Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "51-0000 Production Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.32 (HIL — ~32% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
18.2% CapEx / Revenue (High-CapEx Infrastructure)
High
SEC-XBRL
sec_cik
0001269026
High
SEC-EDGAR
ticker
SINT
High
SEC-EDGAR